EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nanoparticles Designed Based on the Blood‐Brain Barrier for the Treatment of Cerebral Ischemia‐Reperfusion Injury

Zhi-Wei Du, Yao-Sheng Li, Xin-Chi Jiang, Jian-Qing Gao iD

Small · 2025-05 · 21 (19)

DOI: 10.1002/smll.202410404 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 05.03.2025. Verfasst von Zhi-Wei Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 3100…. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Reperfusion Injury, Nanoparticles, Brain Ischemia. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 159 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province, Science and Technology Innovation 2025 Major Project of Ningbo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral ischemia‐reperfusion injury (CI/RI) is currently considered a significant factor affecting the prognosis of ischemic stroke. The blood‐brain barrier (BBB) plays multiple roles in the treatment ofCI/RI. BBB leakage allows bloodborne toxins to exacerbate the stroke pathology. Yet as the physiological barrier that separates the blood from the brain, BBB also poses a significant obstacle to therapeutic drug delivery. Therefore, it is essential to consider both crossing and repairing the BBB in the process of the treatment of CI/RI. Leveraging the exceptional benefits of nanoparticles (NPs) for BBB penetration and targeted repair, numerous NPs are developed as promising drug delivery platforms. Considering the complex role of the BBB in CI/RI, this review delves into the strategies for designing NPs to cross the BBB, focusing on peptide‐modified NPs, cell‐mediated NPs, cell membrane‐derived NPs, and BBB‐modulating NPs. Additionally, it summarizes design strategies of NPs targeting endothelial cells (ECs), astrocytes, and those aimed at regulating the microenvironment to repair the BBB. On this basis, it reveals the prospects and challenges of NPs designed around the BBB in CI/RI treatment. And it highlights the need to combine BBB permeability promotion and BBB repair in nanoparticle strategies designed based on the BBB to achieve more effective treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierReperfusion InjuryNanoparticlesBrain IschemiaHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

blood‐brain barrierischemia‐reperfusion injurynanoparticlestargeting delivery

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Drug Delivery and Release Systems, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, P. R. China.
  • Hangzhou Institute of Innovative Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, 310058, P. R. China.

ORCID-Profile: Jian-Qing Gao

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Zhejiang Province
  • Science and Technology Innovation 2025 Major Project of Ningbo

Zitieren

APA

Du, Z. W., Li, Y. S., Jiang, X. C., & Gao, J. Q. (2025). Nanoparticles Designed Based on the Blood‐Brain Barrier for the Treatment of Cerebral Ischemia‐Reperfusion Injury. Small, 21(19). https://doi.org/10.1002/smll.202410404

Vancouver

Du ZW, Li YS, Jiang XC, Gao JQ. Nanoparticles Designed Based on the Blood‐Brain Barrier for the Treatment of Cerebral Ischemia‐Reperfusion Injury. Small. 2025;21(19). doi:10.1002/smll.202410404

BibTeX
@article{Du2025,
  author = {Du, Zhi-Wei and Li, Yao-Sheng and Jiang, Xin-Chi and Gao, Jian-Qing},
  title = {Nanoparticles Designed Based on the Blood‐Brain Barrier for the Treatment of Cerebral Ischemia‐Reperfusion Injury},
  journal = {Small},
  year = {2025},
  volume = {21},
  number = {19},
  doi = {10.1002/smll.202410404}
}
Kostenlos starten →